Steven Oakland
Known title: DirectorCIK: 0001251543
Associated companies
Transaction History
| ANDE | ▲ Buy | Option Exercise | 2,626 | $0 | 5/7/2026 | View on chart |
| ANDE | ▲ Buy | Grant | 23 | $0 | 5/7/2026 | View on chart |
| ANDE | ▲ Buy | Option Exercise | 2,626 | $0 | 5/7/2026 | View on chart |
| ANDE | ▲ Buy | Grant | 23 | $0 | 5/7/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Andersons (ANDE) Earnings Release Draws Valuation Scrutiny
Recent coverage focuses on whether Andersons is trading below its fair value following its latest earnings report. The stock is currently positioned near a key support level, with technical indicators showing a divergence between revenue and price over the past six months. Analysts maintain an average price target of $88.33, which sits above the current trading range.
Andersons (ANDE) Earnings Release Draws Valuation Scrutiny. Recent coverage focuses on whether Andersons is trading below its fair value following its latest earnings report. The stock is currently positioned near a key support level, with technical indicators showing a divergence between revenue and price over the past six months. Analysts maintain an average price target of $88.33, which sits above the current trading range.